CAMEROON: Malaria May Boost Mother-to-Child HIV Infection

CAMEROON: Malaria May Boost Mother-to-Child HIV Infection - Study

Important note: Information in this article was accurate in 2005. The state of the art may have changed since the publication date.

CAMEROON: Malaria May Boost Mother-to-Child HIV Infection - Study

Reuters (11.18.05) - Wednesday, December 14, 2005
Tansa Musa

Mother-to-child HIV transmission (MTCT) may be more likely when the mother is also infected with malaria, suggests a study presented at the Fourth Multilateral Initiative on Malaria (MIM) Pan-African Malaria Conference 2005, held Nov. 13-18 in Yaounde, Cameroon. An international team of researchers investigated the correlation after noticing MTCT increased at the end of the rainy season, when malaria is most prevalent.

In Cameroon, researchers from the Cameroon Pasteur Center and the Paris-based Pasteur Institute studied the placentas of HIV-positive and -negative pregnant women with or without malaria. They found that malaria infection boosts production of a substance that could increase HIV replication in the placenta, preventing it from protecting the fetus.

"Our research highlights the fact that placental malaria. could play an important role in mother-to-child HIV transmission in utero that has been underestimated," said Anfumbom Kfutwah, a Cameroon Pasteur Center virologist.

"Each disease by itself is a major problem both for the individuals affected and the health care system," said Andreas Heddini, MIM's secretariat coordinator. "But the fact that they frequently occur together is a major complicating factor, and we need more research to clarify how the two infections interact and how best to treat co-infection."

A correlation could prompt health officials to consider routinely screening pregnant women for both diseases and treating malaria to reduce MTCT, said Kfutwah.
051214
AD052516

Copyright © 2005 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2005. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2005. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.